相关实验视频

Updated: May 16, 2025

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

基底腺结石化:"法尔氏病"

Francesca Magrinelli¹, Aaron Jesuthasan², Kailash P Bhatia¹

¹Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.

Practical neurology

|April 1, 2025

概括

初级家族性脑化 (PFBC) 涉及遗传性疾病,导致脑中的积累. 研究揭示了关键的遗传联系和致病机制,为潜在的治疗提供了洞察力.

科学领域:

神经科学是一个神经科学.
遗传学遗传学是一个
生物化学生物化学

背景情况:

大脑化,特别是基底腺的化,呈现出广泛的差异诊断.
初级家族性脑化 (PFBC),以前称为法尔病,是一种神经疾病,其特点是双边,对称的-酸晶体沉积在大脑中.
据推测,PFBC具有遗传病因,并表现为各种运动,认知和精神症状.

研究的目的:

提供对初级家族脑化 (PFBC) 的全面概述.
详细介绍PFBC的表型谱,诊断方法,病原发生和管理策略.
突出了解PFBC的遗传基础和潜在机制的最新进展.

主要方法:

对将特定基因与PFBC联系起来的遗传研究进行审查.
分析已识别的病理机制,包括酸盐阻断和血脑屏障完整性的分析.
综合当前关于临床特征,诊断和治疗的知识.

主要成果:

自2012年以来,已经确定了七个与PFBC相关的基因,具有自体主导或递归遗传模式.
汇聚的病理机制包括无机酸盐两体静止,内皮功能受损,以及血液-大脑屏障完整性受损.
基因发现显著提高了对PFBC病原体的理解.

结论:

PFBC是一种具有可识别分子通路的遗传异质性疾病.
了解这些病理机制为新的疾病修饰疗法提供了潜在的目标.
综合基因,临床和病理机制见解的综合方法对于管理PFBC至关重要.

关键词:

血脑屏障是什么? 血脑屏障是什么?临床神经学临床神经学认知能力认知能力这是遗传学.运动障碍运动障碍

更多相关视频

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...